We are pleased to launch the latest edition of the o2h Kickstarter for Peptide, specifically designed to support early-stage biotech companies advancing peptide-based therapeutics.

Building on the success of the o2h Kickstarter Award over the past three years, and in response to growing demand from the biotech community, this edition extends our structured, execution-focused approach to peptide programmes.

If you are an early-stage biotech founder looking to accelerate your peptide discovery projects, applications are now open. Given the limited number of awards available, we encourage interested companies to apply early via the link here.

Stage 1 includes the synthesis of 100 high-purity peptides (at a fraction of the usual cost) across linear and cyclic formats, alongside 25 ADME data points to assess permeability, stability, and solubility.

Winners can also extend their peptide programme with additional biology support at 20% discount, spanning target engagement, validation, and assay development.

To learn more about the o2h Peptide Kickstarter Award, including the terms, scope and eligibility criteria, please visit o2hdiscovery.co/o2h-kickstarter-peptide/ or write to us at discovery@o2h.com. 

The award is limited to 10 selected companies. We encourage interested teams to apply early.

If this is not directly relevant, please feel free to share it with someone in your network who may benefit.